These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9145069)

  • 1. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
    Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
    J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localization of insulinomas and gastrinomas. Experience of 54 cases].
    Mirallié E; Pattou F; Malvaux P; Filoche B; Godchaux JM; Maunoury V; Palazzo L; Lefebvre J; Huglo D; Paris JC; Carnaille B; Proye C
    Gastroenterol Clin Biol; 2002 Apr; 26(4):360-6. PubMed ID: 12070411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
    Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
    Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptor scintigraphy in gastrinomas.
    Jensen RT; Gibril F
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
    Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
    Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Somatostatin receptor scintigraphy and endoscopic ultrasound for the diagnosis of insulinoma and gastrinoma].
    Zimmer T; Stölzel U; Liehr RM; Bäder M; Fett U; Hamm B; Wiedenmann B; Riecken EO
    Dtsch Med Wochenschr; 1995 Jan; 120(4):87-93. PubMed ID: 7835241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas.
    Zimmer T; Stölzel U; Bäder M; Koppenhagen K; Hamm B; Buhr H; Riecken EO; Wiedenmann B
    Gut; 1996 Oct; 39(4):562-8. PubMed ID: 8944566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
    Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Neuhaus C; Lenze H; Trautmann ME; Arnold R
    Horm Metab Res Suppl; 1993; 27():28-35. PubMed ID: 8330869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
    Modlin IM; Cornelius E; Lawton GP
    Arch Surg; 1995 Apr; 130(4):367-73; discussion 373-4. PubMed ID: 7710334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy.
    Proye C; Malvaux P; Pattou F; Filoche B; Godchaux JM; Maunoury V; Palazzo L; Huglo D; Lefebvre J; Paris JC
    Surgery; 1998 Dec; 124(6):1134-43; discussion 1143-4. PubMed ID: 9854595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy].
    Carnaille B
    Ann Chir; 2000 Jul; 125(6):595-6. PubMed ID: 10986776
    [No Abstract]   [Full Text] [Related]  

  • 13. Somatostatin receptor scintigraphy in carcinoids, gastrinomas and Cushing's syndrome.
    Krenning EP; Kwekkeboom DJ; Oei HY; de Jong RJ; Dop FJ; de Herder WW; Reubi JC; Lamberts SW
    Digestion; 1994; 55 Suppl 3():54-9. PubMed ID: 7698538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imaging methods in diagnosis of neuroendocrine tumors of the gastrointestinal tract].
    Zimmer T; Faiss S; Buhr HJ; Hamm B; Wiedenmann B
    Bildgebung; 1995 Mar; 62(1):5-13. PubMed ID: 7756824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Receptor scintigraphy in endocrine gastrointestinal and pancreatic tumors].
    Joseph K; Stapp J; Reinecke J; Höffken H; Benning R; Neuhaus C; Trautmann ME; Schwerk WB; Arnold R
    Dtsch Med Wochenschr; 1992 Jun; 117(26):1025-8. PubMed ID: 1352234
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
    Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
    J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
    Gibril F; Reynolds JC; Doppman JL; Chen CC; Venzon DJ; Termanini B; Weber HC; Stewart CA; Jensen RT
    Ann Intern Med; 1996 Jul; 125(1):26-34. PubMed ID: 8644985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Somatostatin receptor scintigraphy in neuroendocrine tumors exemplified by a patient with hepatic metastases of gastrinoma].
    Behr T; Becker W; Koch W; Grebmeier J; Wolf F
    Z Gastroenterol; 1994 Feb; 32(2):100-4. PubMed ID: 7513113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.
    Virgolini I; Raderer M; Kurtaran A; Angelberger P; Banyai S; Yang Q; Li S; Banyai M; Pidlich J; Niederle B; Scheithauer W; Valent P
    N Engl J Med; 1994 Oct; 331(17):1116-21. PubMed ID: 7935635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.